Olympus Partners has acquired PAI Pharma, a US-based manufacturer of generic oral liquids. No financial terms were disclosed. Kurt Orlofski serves as CEO of PAI. PAI Pharma has two large manufacturing ...

Sigachi Industries is a constituent of BSE Smallcap index. It is engaged in the manufacturing of Microcrystalline Cellulose ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...